FATE - Wall Street Estimates - Fate Therapeutics, Inc.

Healthcare - Biotechnology - NASDAQ - US

$ 1.27

1.6 %

$ 145 M

Market Cap

-0.77

P/E

Price Target Average

349.94%

Revenue Forecast Estimate

--4.33%

EBIT Estimate

33.66%

Net Income Estimate

7.46%

WALL STREET ESTIMATES

Wall Street Analysts Price Targets Fate Therapeutics, Inc.

Wall Street analysts predict an average 1-year price target for FATE of $5.71 , with forecasts ranging from a low of $4 to a high of $9 .

FATE Lowest Price Target Wall Street Target

4 USD 214.96%

FATE Average Price Target Wall Street Target

5.71 USD 349.94%

FATE Highest Price Target Wall Street Target

9 USD 608.66%

REVENUE FORECAST

EBIT FORECAST

NET INCOME FORECAST

Free